Monoclonal Mouse anti‑Rat GABRD Antibody (clone S151‑3, aa15‑34, WB) LS‑C109039
Monoclonal Mouse anti‑Rat GABRD Antibody (clone S151‑3, aa15‑34, WB) LS‑C109039
Antibody:
GABRD Mouse anti-Rat Monoclonal (aa15-34) (S151-3) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
GABRD Mouse anti-Rat Monoclonal (aa15-34) (S151-3) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
GABRD antibody LS-C109039 is an unconjugated mouse monoclonal antibody to GABRD (aa15-34) from rat. It is reactive with mouse and rat. Validated for ICC and WB.
Target
Rat GABRD
Synonyms
GABRD | EIG10 | GEFSP5 | GABA(A) receptor, delta | EJM7 | GABA A receptor delta | GABA(A) receptor subunit delta
Reactivity
Rat, Mouse
(tested or 100% immunogen sequence identity)
Clonality
IgG2a
Monoclonal
Conjugations
Unconjugated.
Also available conjugated with
Atto 594,
Atto 488,
AP,
APC,
Biotin,
FITC,
PerCP,
Atto 390,
RPE.
Purification
Protein G purified from tissue culture supernatant
Immunogen
Synthetic peptide amino acids 15-34 of rat GABA-A-R-Delta, accession number P18506.
Specificity
Detects ~55 kD protein.
Applications
- ICC (0.1 - 1 µg/ml)
- Western blot (1 - 10 µg/ml)
Usage
Western Blot: Use the lysate in SDS buffer but without boiling, incubating for 20 mins at 37°C instead.
Presentation
PBS, pH 7.4, 0.09% Sodium Azide, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Rat, Mouse
Applications:
ICC, Immunofluorescence, Western blot
Species:
Human, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Species:
Human, Mouse, Rat, Bat, Bovine, Dog, Guinea pig, Hamster, Horse, Rabbit
Applications:
IHC, IHC - Paraffin, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/15/2025